Progress in Clinical Neurosciences: A forum on the early management of Parkinson's disease

被引：4
作者：
Lang, AE
Miyasaki, J
Olanow, CW
Stoessl, AJ
Suchowersky, O
机构：
[1] Univ Toronto, Toronto Western Hosp, Movement Disorders Ctr, Div Neurol,Dept Med, Toronto, ON M5T 2S8, Canada
[2] Mt Sinai Sch Med, Dept Neurol, Toronto, ON, Canada
[3] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V5Z 1M9, Canada
[4] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
来源：
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 2005年 / 32卷 / 03期
关键词：
D O I：
10.1017/S0317167100004145
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
There are numerous concerns related to treatment choices involving early dopaminergic therapy in Parkinson's disease. These include the effect on the underlying progression of the neurodegenerative process as well as the development of motor complications such as fluctuations and dyskinesias. A number of recent basic and clinical studies have provided new insights but have also added confusion and controversy. This report summarizes presentations and discussion dealing with these issues from a one-day symposium involving Canadian Movement Disorders neurologists.
引用
收藏
页码：277 / 286
页数：10
相关论文
共 110 条
[1]   Slowing Parkinson's disease progression - Recent dopamine agonist trials [J].
Ahlskog, JE .
NEUROLOGY, 2003, 60 (03) :381-389
[2]   Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature [J].
Ahlskog, JE ;
Muenter, MD .
MOVEMENT DISORDERS, 2001, 16 (03) :448-458
[3]  
Ahlskog JE, 1999, MOVEMENT DISORD, V14, P940, DOI 10.1002/1531-8257(199911)14:6<940::AID-MDS1005>3.0.CO
[4]  
2-Y
[5]   Initial agonist treatment of Parkinson disease - A critique [J].
Albin, RL ;
Frey, KA .
NEUROLOGY, 2003, 60 (03) :390-394
[6]  
[Anonymous], 1996, Ann Neurol, V39, P29
[7]   Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease [J].
Antonini, A ;
Leenders, KL ;
Vontobel, P ;
Maguire, RP ;
Missimer, J ;
Psylla, M ;
Günther, I .
BRAIN, 1997, 120 :2187-2195
[8]   Parkinson's disease and sleepiness - An integral part of PD [J].
Arnulf, I ;
Konofal, E ;
Merino-Andreu, M ;
Houeto, JL ;
Mesnage, V ;
Welter, ML ;
Lacomblez, L ;
Golmard, JL ;
Derenne, JP ;
Agid, Y .
NEUROLOGY, 2002, 58 (07) :1019-1024
[9]   6-YEAR RESULTS OF TREATMENT WITH LEVODOPA PLUS BENZERAZIDE IN PARKINSONS-DISEASE [J].
BARBEAU, A ;
ROY, M .
NEUROLOGY, 1976, 26 (05) :399-404
[10]   CHRONIC TREATMENT WITH L-DOPA, BUT NOT BROMOCRIPTINE INDUCES DYSKINESIA IN MPTP-PARKINSONIAN MONKEYS - CORRELATION WITH [H-3] SPIPERONE BINDING [J].
BEDARD, PJ ;
DIPAOLO, T ;
FALARDEAU, P ;
BOUCHER, R .
BRAIN RESEARCH, 1986, 379 (02) :294-299
12345678910